Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tenofovir disoproxil fumarate (substance) |
Is a |
False |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tenofovir disoproxil (substance) |
Is a |
False |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tenofovir 300mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing emtricitabine and rilpivirine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing emtricitabine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing efavirenz and emtricitabine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing emtricitabine and tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Tenofovir alafenamide (substance) |
Is a |
False |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Tenofovir alafenamide (substance) |
Is modification of (attribute) |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tenofovir disoproxil (substance) |
Is modification of (attribute) |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing bictegravir and emtricitabine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only bictegravir and emtricitabine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cobicistat and elvitegravir and emtricitabine and tenofovir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only emtricitabine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Efavirenz and emtricitabine and tenofovir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only emtricitabine and rilpivirine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bictegravir and emtricitabine and tenofovir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Emtricitabine and tenofovir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Efavirenz and emtricitabine and tenofovir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only doravirine and lamivudine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing doravirine and lamivudine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing doravirine and lamivudine and tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only doravirine and lamivudine and tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Efavirenz- and lamivudine- and tenofovir-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Efavirenz and lamivudine and tenofovir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Efavirenz- and lamivudine- and tenofovir-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Efavirenz and lamivudine and tenofovir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only dolutegravir and lamivudine and tenofovir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dolutegravir- and lamivudine- and tenofovir-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lamivudine- and tenofovir-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing lamivudine and tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lamivudine and tenofovir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lamivudine and tenofovir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Emtricitabine and rilpivirine and tenofovir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tenofovir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |